Developer docs
API playgroundTry for free, no card

Search company profiles

Arkin Holdings

Full company profile

uuid0000peh

Namestring
Arkin Holdings
Legal namestring
Arkin Capital
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Arkin Holdings, operating commercially as Arkin Capital, is a privately-held multi-asset investment management firm headquartered in Herzliya, Israel, founded in 2008. The firm manages over $2 billion in assets under management across venture capital, private equity, and hedge funds, deploying capital through four specialized investment arms: Arkin Health (early to late-stage biotech, digital health, and public pharmaceutical companies via sub-brands Arkin Bio, A-Squared Ventures, and Sphera Health), Arkin Equity (Israeli public markets and private equity via Idea Hedge Fund, Arkin Private Equity, and Arkin Foundry), Arkin Tech (early-stage technology companies), and Arkin Real Estate (residential, commercial, and industrial properties across North America and Europe). The firm's portfolio of 30+ companies spans biotechnology, digital health, cybersecurity, food technology, renewable energy, cloud computing, fintech, and real estate, with notable investments including DigitalOcean, Lendbuzz, Via, HoneyBook, Keros Therapeutics, HI-Bio, Cellebrite, TopGum, Phytolon, Eleos, and Laguna.

The firm generates revenue through management fees, carried interest, and investment returns on its multiple fund vehicles, distributing investment offerings through direct relationships with institutional investors, family offices, and qualified investors. Its go-to-market relies on thematic brand-building via the arkin-capital.com website, which showcases portfolio companies, investment thesis, and team expertise. Most recently, the firm raised a $100 million dedicated biotech fund in January 2026 to deepen its Arkin Health vertical.

The firm was founded by Dan Goldstaub and is chaired by Agnete Nielsen. Geographically, operations span Israel (Tel Aviv, Herzliya), the United States (Boston, New York, San Francisco), and Europe (Sweden, Germany). Core customers are portfolio companies seeking capital and strategic support across growth stages, and limited partners providing fund commitments. Underlying technical assets are limited to investment infrastructure; the firm does not develop proprietary technology products but selectively invests in AI-enabled companies such as Lendbuzz, Eleos, and Laguna.

Short descriptiontext

Arkin Holdings (Arkin Capital) is a privately-held Israeli multi-asset investment manager with over $2 billion AUM, deploying capital across biotech, digital health, private equity, early-stage tech, and real estate through four specialized investment arms and 30+ portfolio companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
multi-asset investment management, venture capital funds, private equity investments, biotech and digital health, global real estate investing
Industry1 code
PRIMARYFSAAAKAL
Real Assets — Operating Platforms & Direct Investments
Financial & Insurance/Asset & Wealth Management/Asset Management — Real Assets (Real Estate, Infrastructure, Natural Resources)
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • All Other Financial Investment Activities52399
  • Other Financial Vehicles52599
SIC code2 codes
  • Investors, Nec6799
  • Real Estate Dealers (For Their Own Account)6532
Product category
Multi-Asset Investment Management
No data
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 10 records shown
1Arkin Health
Description

Investment arm focused on health technologies including early to late-stage biotech, digital health startups, and public pharmaceutical companies.

arkin-capital.com
+9 more records
Core offering1 text field

Arkin Holdings (Arkin Capital) is a privately held multi-asset investment management firm with over $2 billion in assets under management across venture capital, private equity, hedge funds, and real estate. The company deploys capital through four specialized investment arms (Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate) targeting biotech, digital health, private equity, Israeli public markets, early-stage technology, and global real estate opportunities. It has made over 30 notable investments including DigitalOcean, Lendbuzz, Via, HoneyBook, Keros Therapeutics, HI-Bio, Cellebrite, and Fu-Gen.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Arkin Capital is a multi-asset investment management firm with over $2 billion under management across VC, PE, and Hedge Funds. The company operates through four distinct investment arms rather than offering a unified product platform. Arkin Health invests in early to late-stage biotech, digital health startups, and public pharmaceutical companies through sub-brands including Arkin Bio, A-Squared Ventures, and Sphera Health. Arkin Equity manages private equity and Israeli public markets through Idea Hedge Fund, Arkin Private Equity, and Arkin Foundry. Arkin Tech focuses on early-stage technology companies with notable investments in DigitalOcean, Lendbuzz, Via, and HoneyBook. Arkin Real Estate invests in global real estate across North America and Europe in residential, commercial, and industrial markets. The investment firm's portfolio includes companies across biotechnology, digital health, cybersecurity, food technology, renewable energy, cloud computing, and real estate sectors.

Product and service10 records
1Arkin Health
CategoryHealthcare and Biotech Investment
Description

Investment arm investing in early to late-stage biotech, digital health startups, and public pharmaceutical companies, accelerating life-changing therapies and driving the future of healthcare. Includes sub-brands Arkin Bio, A-Squared Ventures, and Sphera Health.

2Arkin Equity
3Arkin Tech
4Arkin Real Estate
5Arkin Bio
CategoryBiotech Investment
Description

Subsidiary of Arkin Health focusing on biotech investments.

6A-Squared Ventures
7Sphera Health
8Idea Hedge Fund
9Arkin Private Equity
10Arkin Foundry
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global healthcare-focused investment firm spanning venture, growth, and public equities. Directly comparable to Arkin Health/Bio given its sector depth across biotech and digital health.

TypeDirect peer
Description

Israeli-listed biotech and healthcare investment holding company. Comparable to Arkin Bio given its Israeli roots and public-markets exposure to life sciences.

TypeDirect peer
Description

Israeli technology-focused investment holding company with multi-stage venture holdings. Comparable to Arkin Tech and overall Arkin Holdings holding-company structure.

TypeDirect peer
Description

Israeli healthcare-dedicated venture capital firm. Directly comparable to Arkin Bio and A-Squared Ventures given shared Israel/healthcare focus and similar stage investments.

TypeDirect peer
Description

Israeli venture investment platform backing early-to-growth stage tech and health companies. Comparable to Arkin Tech given Israeli early-stage tech orientation.

TypeDirect peer
Description

Israeli early-to-growth stage venture capital firm with technology focus. Comparable to Arkin Tech given Israeli tech investing mandate.

7Infinity Group
TypeDirect peer
Description

Israeli multi-asset investment firm with private equity and public-market activities. Closely comparable to Arkin Equity given parallel Israeli multi-strategy platform.

8Discount Capital
TypeDirect peer
Description

Israeli alternative investment manager covering private equity, hedge funds, and credit. Comparable to Arkin Equity given Israeli roots and multi-pool capital structure.

TypeBroad incumbent
Description

Global multi-alternative asset manager with private equity, real estate, hedge fund, and growth/VC arms. Comparable to Arkin Holdings at the multi-strategy platform level but operates at vastly greater scale.

10KKR
TypeBroad incumbent
Description

Global multi-alternative asset manager with PE, real estate, credit, and infrastructure. Broadly comparable multi-arm structure to Arkin's four investment pillars, though at materially larger AUM.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment31 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arkin Holdings

Multi-Asset Investment Managementarkinholdings.com

Arkin Holdings (Arkin Capital) is a privately-held Israeli multi-asset investment manager with over $2 billion AUM, deploying capital across biotech, digital health, private equity, early-stage tech, and real estate through four specialized investment arms and 30+ portfolio companies.

What Arkin Holdings does

Arkin Holdings, operating commercially as Arkin Capital, is a privately-held multi-asset investment management firm headquartered in Herzliya, Israel, founded in 2008. The firm manages over $2 billion in assets under management across venture capital, private equity, and hedge funds, deploying capital through four specialized investment arms: Arkin Health (early to late-stage biotech, digital health, and public pharmaceutical companies via sub-brands Arkin Bio, A-Squared Ventures, and Sphera Health), Arkin Equity (Israeli public markets and private equity via Idea Hedge Fund, Arkin Private Equity, and Arkin Foundry), Arkin Tech (early-stage technology companies), and Arkin Real Estate (residential, commercial, and industrial properties across North America and Europe). The firm's portfolio of 30+ companies spans biotechnology, digital health, cybersecurity, food technology, renewable energy, cloud computing, fintech, and real estate, with notable investments including DigitalOcean, Lendbuzz, Via, HoneyBook, Keros Therapeutics, HI-Bio, Cellebrite, TopGum, Phytolon, Eleos, and Laguna.

The firm generates revenue through management fees, carried interest, and investment returns on its multiple fund vehicles, distributing investment offerings through direct relationships with institutional investors, family offices, and qualified investors. Its go-to-market relies on thematic brand-building via the arkin-capital.com website, which showcases portfolio companies, investment thesis, and team expertise. Most recently, the firm raised a $100 million dedicated biotech fund in January 2026 to deepen its Arkin Health vertical.

The firm was founded by Dan Goldstaub and is chaired by Agnete Nielsen. Geographically, operations span Israel (Tel Aviv, Herzliya), the United States (Boston, New York, San Francisco), and Europe (Sweden, Germany). Core customers are portfolio companies seeking capital and strategic support across growth stages, and limited partners providing fund commitments. Underlying technical assets are limited to investment infrastructure; the firm does not develop proprietary technology products but selectively invests in AI-enabled companies such as Lendbuzz, Eleos, and Laguna.

Arkin Holdings firmographics

Firmographics
Name
Arkin Holdings
Legal name
Arkin Capital
Website
https://arkinholdings.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Arkin Holdings (Arkin Capital) is a privately-held Israeli multi-asset investment manager with over $2 billion AUM, deploying capital across biotech, digital health, private equity, early-stage tech, and real estate through four specialized investment arms and 30+ portfolio companies.
Ownership category
akta.pro rank

Arkin Holdings industry classification

Industry
Product category
Multi-Asset Investment Management
NAICS
Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399), Other Financial Vehicles (52599)
SIC
Investors, Nec (6799), Real Estate Dealers (For Their Own Account) (6532)
akta.pro industry
PRIMARYFSAAAKAL
Real Assets — Operating Platforms & Direct Investments
Financial & Insurance/Asset & Wealth Management/Asset Management — Real Assets (Real Estate, Infrastructure, Natural Resources)

Keywords

  • Multi-asset investment management
  • Venture capital funds
  • Private equity investments
  • Biotech and digital health
  • Global real estate investing

Where Arkin Holdings is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Markets served

Arkin Holdings business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Marketing channels1 record

Arkin Holdings product offering

Product offering

Core offering

Arkin Holdings (Arkin Capital) is a privately held multi-asset investment management firm with over $2 billion in assets under management across venture capital, private equity, hedge funds, and real estate. The company deploys capital through four specialized investment arms (Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate) targeting biotech, digital health, private equity, Israeli public markets, early-stage technology, and global real estate opportunities. It has made over 30 notable investments including DigitalOcean, Lendbuzz, Via, HoneyBook, Keros Therapeutics, HI-Bio, Cellebrite, and Fu-Gen.

Product overview

Arkin Capital is a multi-asset investment management firm with over $2 billion under management across VC, PE, and Hedge Funds. The company operates through four distinct investment arms rather than offering a unified product platform. Arkin Health invests in early to late-stage biotech, digital health startups, and public pharmaceutical companies through sub-brands including Arkin Bio, A-Squared Ventures, and Sphera Health. Arkin Equity manages private equity and Israeli public markets through Idea Hedge Fund, Arkin Private Equity, and Arkin Foundry. Arkin Tech focuses on early-stage technology companies with notable investments in DigitalOcean, Lendbuzz, Via, and HoneyBook. Arkin Real Estate invests in global real estate across North America and Europe in residential, commercial, and industrial markets. The investment firm's portfolio includes companies across biotechnology, digital health, cybersecurity, food technology, renewable energy, cloud computing, and real estate sectors.

Differentiator

Problem solved

Functional benefit

Brands

  • Arkin Health: Investment arm focused on health technologies including early to late-stage biotech, digital health startups, and public pharmaceutical companies.
  • Arkin Equity
  • Arkin Tech
  • Arkin Real Estate
  • Arkin Bio
  • A-Squared Ventures
  • Sphera Health
  • Idea Hedge Fund
  • Arkin Private Equity
  • Arkin Foundry

Products and services

  • Arkin Health Investment arm investing in early to late-stage biotech, digital health startups, and public pharmaceutical companies, accelerating life-changing therapies and driving the future of healthcare. Includes sub-brands Arkin Bio, A-Squared Ventures, and Sphera Health.
  • Arkin Equity
  • Arkin Tech
  • Arkin Real Estate
  • Arkin Bio Subsidiary of Arkin Health focusing on biotech investments.
  • A-Squared Ventures
  • Sphera Health
  • Idea Hedge Fund
  • Arkin Private Equity
  • Arkin Foundry

Companies that use Arkin Holdings

Customer profile

Segments1 record

Ideal customer profiles2 records

Arkin Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Arkin Holdings partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights2 records

Arkin Holdings competitors and assessment

Company assessment

Direct peers

  • OrbiMed: Global healthcare-focused investment firm spanning venture, growth, and public equities. Directly comparable to Arkin Health/Bio given its sector depth across biotech and digital health.
  • Clal Biotechnology Industries: Israeli-listed biotech and healthcare investment holding company. Comparable to Arkin Bio given its Israeli roots and public-markets exposure to life sciences.
  • Elron Electronic Industries: Israeli technology-focused investment holding company with multi-stage venture holdings. Comparable to Arkin Tech and overall Arkin Holdings holding-company structure.
  • Pontifax: Israeli healthcare-dedicated venture capital firm. Directly comparable to Arkin Bio and A-Squared Ventures given shared Israel/healthcare focus and similar stage investments.
  • OurCrowd: Israeli venture investment platform backing early-to-growth stage tech and health companies. Comparable to Arkin Tech given Israeli early-stage tech orientation.
  • Jerusalem Venture Partners (JVP): Israeli early-to-growth stage venture capital firm with technology focus. Comparable to Arkin Tech given Israeli tech investing mandate.
  • Infinity Group: Israeli multi-asset investment firm with private equity and public-market activities. Closely comparable to Arkin Equity given parallel Israeli multi-strategy platform.
  • Discount Capital: Israeli alternative investment manager covering private equity, hedge funds, and credit. Comparable to Arkin Equity given Israeli roots and multi-pool capital structure.

Broad incumbents

  • Blackstone: Global multi-alternative asset manager with private equity, real estate, hedge fund, and growth/VC arms. Comparable to Arkin Holdings at the multi-strategy platform level but operates at vastly greater scale.
  • KKR: Global multi-alternative asset manager with PE, real estate, credit, and infrastructure. Broadly comparable multi-arm structure to Arkin's four investment pillars, though at materially larger AUM.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Arkin Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arkin Holdings leadership team

Management profile

Number of profiles

Profiles2 records

Arkin Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arkin Holdings M&A and investment

M&A and investment

M&A1 record

Investments31 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arkin Holdings

What does Arkin Holdings do?

Arkin Holdings (Arkin Capital) is a privately held multi-asset investment management firm with over $2 billion in assets under management across venture capital, private equity, hedge funds, and real estate. The company deploys capital through four specialized investment arms (Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate) targeting biotech, digital health, private equity, Israeli public markets, early-stage technology, and global real estate opportunities. It has made over 30 notable investments including DigitalOcean, Lendbuzz, Via, HoneyBook, Keros Therapeutics, HI-Bio, Cellebrite, and Fu-Gen.

Is Arkin Holdings a public or private company?

Arkin Holdings is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Arkin Holdings founded?

Arkin Holdings was founded in 2009. It employs 11 to 50 people.

Where is Arkin Holdings based?

Arkin Holdings is headquartered in Herzliya, Israel, in the Middle East region.

Who are Arkin Holdings's main competitors?

Direct peers on record are OrbiMed, Clal Biotechnology Industries, Elron Electronic Industries, Pontifax, OurCrowd, Jerusalem Venture Partners (JVP), Infinity Group and Discount Capital. Broad incumbents are Blackstone and KKR.

Does Arkin Holdings have an API?

No public API is recorded for Arkin Holdings.

What industry is Arkin Holdings in?

Arkin Holdings's product category is Multi-Asset Investment Management. Its primary akta.pro industry code is FSAAAKAL, Real Assets — Operating Platforms & Direct Investments. Its NAICS code is 523940 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GreenqueenMolecular Farming Startup Plantopia Bags $9M to Grow Dairy Proteins in OatsIsraeli food tech startup Plantopia has raised $9 million in a funding round led by dairy giant Schreiber Foods and VC firm Siddhi Capital, with participation from Yotvata Dairy, Arkin Capital, and Fresh Start FoodTech Incubator, bringing its total funding beyond $16 million. The company will use the funds to establish a manufacturing facility in Kibbutz Sdot Yam, Israel, to produce casein proteins in sprouted oats for animal-free dairy alternatives like mozzarella. Plantopia has successfully expressed all four casein protein forms and targets pricing of $15-20 per kilogram, positioning itself to serve the growing GLP-1 nutrition market while offering a climate-resilient alternative to conventional dairy.Pulse 2.0Arkin Capital Closes $100 Million Bio Ventures III Fund For Early-Stage Biotech InvestingArkin Capital closed Arkin Bio Ventures III, a $100 million fund for advanced pre-clinical and early clinical-stage biotech companies. The fund will invest in 10-12 companies globally, focusing on oncology, immunology, and other high-impact areas. Arkin Bio now manages over $600 million in biotech-focused assets.GeektimeIsraeli development offers photonic encryption of data over optical fiberIsraeli cybersecurity startup CyberRidge has developed a photonic transmission technology that encrypts data over optical fiber by transforming it into unrecordable 'encrypted optical noise' using triple optical manipulation, making it immune to interception and quantum decryption. The company, founded in 2022 by Professor Dan Shadot based on research from Ben-Gurion University's Optical Communication Research Laboratory, has completed a $16 million Series A funding round with participation from Arkin, Redseed VC, Elron Ventures, Awz fund, and an EIC grant. The product is already deployed with paying customers and is being tested by intelligence and communication bodies, with demonstrations underway in Europe, Singapore, Australia, and with an elite IDF intelligence unit.Pulse 2.0HI-Bio: $95 Million Raised To Develop Targeted Therapies For Immune-Mediated DiseasesHI-Bio closed a $95 million Series B led by Alpha Wave Global, with Viking Global Investors and Arkin Bio Capital participating. The funds will advance felzartamab, a CD38-targeting antibody, and a new anti-C5aR1 candidate. The company expects Phase 2 results from an investigator-initiated trial for antibody-mediated rejection.CTechPigmentum closes $6 million Seed round for its functional milk proteinsIsraeli startup Pigmentum has closed a $6 million Seed funding round for its technology that produces functional milk proteins from plants, led by Kibbutz Yotvata and Arkin Holdings. The company intends to focus on producing casein to provide alternative dairy manufacturers with non-animal sourced products that mimic real dairy. Existing investors including Tempo and Tnuva joined the round, which follows an earlier investment from the Fresh Start incubator program.CTechArkin Holdings raises $270 million for new biotech fundArkin Holdings raised $270 million for a new biotech fund, Arkin Bio-Capital, which will invest in 8-10 companies developing innovative medicine. The fund, managed by Alon Lazarus and Pini Orbach, received investments from Migdal Insurance, Phoenix, and new institutional investors. It targets pre-IPO rounds of companies planning to go public.GlobesEyal Lapidot takes option on 5% of Clal InsuranceEyal Lapidot, leaving Phoenix Holdings for Shikun & Binui, may buy 5% of Clal Insurance via an option. IDB Development sold 4.99% each to Mori Arkin and Yakir Gabay for NIS 270 million. Lapidot seeks a passive stake, not a managerial role.GlobesAccelmed fund makes 250% on Cogentix exitAccelmed sold its 26.7% stake in Cogentix to Laborie Medical Technologies for $242 million, a 250% return on its investment. The deal includes a 14% premium over Cogentix's market cap, and the company will be delisted.FinSMEsPhoenix Group & Arkin Holdings to Invest $60M in Pharma & Biotech CompaniesPhoenix Group and Arkin Holdings formed Arkin Bio-Ventures to invest about $60 million in pharma and biotech companies. The partnership, with Phoenix managing NIS 160 billion, targets pre-clinical and advanced-stage drug development in Israel and globally.